Composition: Recombinant Hepatitis B Surface Antigen 20mcg
Availability of this product will assure once the Pharmacy partners is confirmed.
Tafvac-B 20mcg Injection is used to prevent chronic hepatitis B virus (HBV) infection.
Tafvac-B 20mcg Injection is a vaccine which helps develop immunity by initiating a mild infection. This type of infection does not cause illness but stimulates the body's immune system to produce antibodies (proteins) to protect against any future infections.
Nausea, Neuropathy, Pain, Paralysis, Abdominal pain, Anaphylactic reaction, Angioedema (swelling of deeper layers of skin), Convulsion, Diarrhoea, Dizziness, Fatigue, Fever, Headache, Decreased blood pressure, Itching, Feeling of discomfort, Meningitis, Muscle pain, Rash, Skin redness, Vomiting, Weakness